Cat. No.: DMM-001293
Status | Age | Sex |
---|---|---|
|
|
|
Model Overview | |
---|---|
Model Description | Ins2l mutant mice possess loxP sites flanking exons 1 to 3 of the Ins2 (insulin 2) gene and may be useful as a conditional mutant for the study of diabetes. |
Strain Name | NOD.Cg-Ins2tm1Mnt/J |
Background Strain | NOD/ShiLtJ |
SPF | Yes |
Research Application | Diabetes |
Target Information | |
---|---|
Target Name | insulin II |
Synonyms | CP-II, IDDM, IDDM1, IDDM2, ILPR, Ins-2, InsII, IRDN, Mody, MODY10, Mody4, PNDM4 |
Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.